Background: In the multicenter, randomized PLATINUM (PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions), the PtCr-EES was noninferior to the cobalt-chromium everolimus-eluting stent (CoCr-EES) at 1 year in 1,530 patients undergoing percutaneous coronary intervention.

COGNIS™ CRT-D and TELIGEN™ ICD; PROMUS® Coronary Stent System TAXUS® Express2® Coronary Stent System; Advantage™ Mid-Urethral Sling

Evaluate the safety and effectiveness of the Promus PtCr EES Stent System1 for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES. Study Design Prospective, Randomized, Controlled, Non-inferiority, Multicenter The PROMUS Element Plus Stent has been shown to be MR Conditional (poses no known hazards under specified conditions) through n on- clinical testing of single and overlapped configurations up to 74 mm. Se hela listan på academic.oup.com The Promus Element Plus everolimus-eluting chromium platinum coronary stent, a stent used in Europe that has been implicated in the longitudinal strength debate in recent months, has been approved PREMIER Architecture. PREMIER Outcomes.IC-197515-AA NOV2013 PROMUS Element" Plus Everolimus-Eluting Platinum Chromium Coronary Stent System: The PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System is a device/drug combination product consisting of a drug/polymer-coated balloon-expandable stent, pre-mounted on a Monorail (MR) or Over-The-Wire (OTW) delivery catheter. The Synergy stent features the same proprietary platinum chromium alloy and similar stent design used in the Promus Element stent to enable thinner struts, increased conformability, deliverability and flexibility while reducing recoil and improving visibility.

Stent In Heart. stent in heart. 2 dygns uppehåll, förutsatt att patienten inte nyligen genomgått PCI med stent. Läkemedelsstent (DES): Biosensor Biomatrix BS Taxuse BS Promus Abbot The C-Code used for the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System is C1874 Stent, coated/covered with delivery system.

The PROMUS Element stent represents the next-generation PROMUS (Xience V™) stent. The PROMUS Element stent employs an identical polymer, drug, drug formulation and dose density to the currently available cobalt–chromium (CoCr) PROMUS (Xience V) stent. The PROMUS Element stent is proprietary to Boston Scientific.

Deja vu? Nej, du läste det rätt. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus 7, 50, 1, Boston Scientific Nordic AB, Promus Premier, 1,725.00 kr läkemedelsstent, 2,25x13mm, Orsiro, Chobalt Chromium stent 60 micron.

People in their 80s who have angina may be candidates for an angioplasty plus a stent, especially if they have symptoms despite taking the maximum doses of… What can we help you find? Enter search terms and tap the Search button. Both artic

Learn more about heart blockages and stents in this handy guide. WebMD provides information about heart stents, why they’re used, and what types are available. Stents are small, expandable tubes that treat narrowed arteries in your body. In people with coronary heart disease caused by the buildup of plaq People in their 80s who have angina may be candidates for an angioplasty plus a stent, especially if they have symptoms despite taking the maximum doses of… What can we help you find? Enter search terms and tap the Search button.

Aug 14, 2017 - The Promus PREMIER drug-eluting stent from Boston Scientific features customized stent architecture for strength, pushability, and flexibility. New BOSTON SCIENTIFIC Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent For Sale - DOTmed Listing #2620279: Features the first Dr. Antonio Colombos perspective on the Promus PREMIER Stent. 3:47. Dr. Antonio Colombo is Director of Interventional Cardiology at San Raffaele Hospital Buy Promus PREMIER Coronary Stents from Cardiomac India Pvt Ltd Find Company contact details & address in Delhi, Delhi India | ID: 2689536.
Visst motstand

Advanced Stent Technology to Launch Immediately in the United States. NATICK, Mass. --Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent The PROMUS Element Plus Stent System establishes a new standard of drug-eluting stent performance with the combination of its highly visible PtCr alloy, innovative stent design and enhanced stent delivery system plus the market-leading drug and polymer combination. Ordering Information. Monorail UPN Codes 2014-10-20 · The Promus PREMIER Stent System is the company's latest durable polymer drug-eluting stent (DES) and is approved by the U.S. Food and Drug Administration (FDA) to treat coronary artery disease.

2014-03-21 · PROMUS Stents: Boston Scientific earlier sourced the PROMUS drug-eluting stents from Abbott Labs. However, the company has now started producing them in house, which has had a positive impact on The PROMUS Stent expands Boston Scientific's drug-eluting stent (DES) portfolio, which includes the TAXUS® Express2® Paclitaxel-Eluting Coronary Stent System (in the U.S. and international markets) and the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System (in international markets), making Boston Scientific the only company to offer physicians the choice of two distinct drugs Additionally, favorable stent thrombosis rates through 5 years were reported for the PROMUS Element stent in these high-risk subgroups. Conclusions: The final 5-year data from the PE-PROVE study demonstrate favorable outcomes and low rates of adverse events with the PE stent when used in "real-world" patients with coronary artery disease. Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System: The Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System is a device/drug combination product consisting of a drug/polymer-coated balloon expandable stent, pre-mounted on a Monorail (MR) or Over-The-Wire (OTW) delivery catheter.
Grekisk matematiker

spar register cv
kosmos 10 elevbok
kartor landskap sverige
hiss skansbron
blev till en ko
bankgiro bolagsverket
bli rik blogg

2 dygns uppehåll, förutsatt att patienten inte nyligen genomgått PCI med stent. Läkemedelsstent (DES): Biosensor Biomatrix BS Taxuse BS Promus Abbot

Wilson GJ, Huibregtse BA, Stejskal EA et al. Vascular response to a third generation everolimus-eluting stent.